US REIT MA Shift PublictoPublic Consolidation Takes the Lead
SP Upgrades Lockheed Martin Outlook Amid Sustained Defense Demand
UK Police to Score Train Operators on Sexual Harassment Response No Financial Penalties for NonCompliance
Nvidia Stock Slips PostEarnings Sellers May Be Overlooking LongTerm Growth Drivers
Government Readies Major Overhaul of Tax Administration to Ensure Smooth India GST Rollout
Kevin Warsh Faces Divided Fed Over Rate Cut Prospects as Inflation and Yields Surge
SMTI Q1 2026 Earnings Profitability Breakthrough Surpasses Estimates
Hoyne Bancorp Inc HYNE Q1 2026 Earnings Negative EPS but Stock Rises Modestly
Dole DOLE Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
STIM Q1 2026 Earnings EPS Beats Estimates as Cost Control Shines Revenue Unreported
CSIQ Q1 2026 Earnings NarrowerThanExpected Loss Shows Cost Discipline Amid Solar Market Challenges
REG Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience
Grupo Televisa TV Edges Higher Key Levels to Watch After a Slight Rally
Penske Automotive Group PAG Edges Higher Amid Sector Strength Key Levels in Focus
CocaCola KO Edges Higher as Stability Prevails
Provident Financial Holdings PROV Holds Steady Near Key Resistance A Narrow Trading Range Emerges
Greenwich LifeSciences Inc GLSI Edges Higher as Shares Approach Key Resistance
Wholesale Inflation Surges 6 Annually in April Marking Largest Increase Since 2022
Equity Lifestyle Properties Inc ELS Q1 2026 Earnings Slight EPS Beat Amid Steady Demand for Manufactured Housing
Hall Chadwick Acquisition Corp Rights HCACR Hold Steady at 032 Waiting for a Catalyst
AVIR Q1 2026 Earnings Narrowerthanexpected Loss Boosts Investor Sentiment
BITF Q1 2026 Earnings EPS Falls Short as Bitcoin Mining Sector Faces Headwinds
YALA Q1 2026 Earnings Positive EPS of 016 Drives Modest Share Uptick
PD Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick
GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline
East West Bancorp Inc EWBC Q1 2026 Earnings EPS Beats Estimates Stock Holds Steady
GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend